Utah Medical Products, Inc. (OQ:UTMD)
Business Focus: Medical Equipment, Supplies & Distribution
Feb 06, 2024 10:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / February 6, 2024 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share of common stock payable on April 3, 2024 to stockholders of record at the close of business on March 15, 2024. This is a 1.7% increase over the dividend declared in the same quarter of the prior year.
Jan 30, 2024 09:00 am ET
UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance
via NewMediaWire – With Revenues 4% lower and Net Income and Earnings Per Share 1% higher than in 2022, Utah Medical Products, Inc. (Nasdaq: UTMD) achieved financial results for the full year of 2023 consistent with management’s beginning of year...
Oct 31, 2023 10:00 am ET
Utah Medical Products, Inc. Increases Regular Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / October 31, 2023 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share of common stock payable on January 3, 2024 to shareholders of record at the close of business on December 15, 2023. This is a 1.7% increase over the prior regular quarterly cash dividend.
Oct 26, 2023 09:00 am ET
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2023
via NewMediaWire – Utah Medical Products, Inc. [Nasdaq: UTMD], despite a difficult third calendar quarter (3Q), achieved financial results for nine months (9M) 2023 consistent with those anticipated in its beginning of year projections. Currencies...
Aug 31, 2023 09:00 am ET
UTMD Updates Status of Filshie Product Liability Lawsuits in the U.S.
SALT LAKE CITY, UT / ACCESSWIRE / August 31, 2023 / As Utah Medical Products, Inc.'s (NASDAQ:UTMD's) stockholders know, the following disclosure was included in the Company's 2022 SEC 10-K annual report, released in March 2023:
Aug 01, 2023 10:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / August 1, 2023 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-nine and one-half cents ($.295) per share of common stock payable on October 3, 2023 to shareholders of record at the close of business on September 15, 2023. This is a 1.7% increase over the dividend declared in the same quarter of the prior year.
Jul 25, 2023 09:00 am ET
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2023
via NewMediaWire – Utah Medical Products, Inc. [Nasdaq: UTMD] achieved second calendar quarter (2Q) and first half (1H) 2023 financial results consistent with those anticipated in its beginning of year projections. Currencies in this release are...
May 09, 2023 10:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / May 8, 2023 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-nine and one-half cents ($.295) per share of common stock payable on July 6, 2023 to stockholders of record at the close of business on June 16, 2023. This is a 1.7% increase over the dividend declared in the same quarter of the prior year.
Apr 25, 2023 09:00 am ET
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2023
via NewMediaWire - In the first calendar quarter (1Q) of 2023, Utah Medical Products, Inc. (Nasdaq: UTMD) attained financial results consistent with achieving its goals previously announced for calendar year 2023. Summary of results....
Feb 07, 2023 10:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / February 7, 2023 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-nine and one-half cents ($.295) per share of common stock payable on April 4, 2023 to shareholders of record at the close of business on March 17, 2023. This is a 1.7% increase over the dividend declared in the same quarter of the prior year.
Jan 31, 2023 09:00 am ET
UTMD Reports Audited Year 2022 and Fourth Quarter Financial Performance
via NewMediaWire – Utah Medical Products, Inc. (Nasdaq: UTMD) finished the calendar year with a solid fourth quarter (4Q) performance, which allowed financial results for the year 2022 exceeding management’s beginning of year projections, despite...
Nov 01, 2022 10:00 am ET
Utah Medical Products, Inc. Increases Regular Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / November 1, 2022 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-nine and one-half cents ($.295) per share of common stock payable on January 4, 2023 to shareholders of record at the close of business on December 16, 2022. This is a 1.7% increase over the prior regular quarterly cash dividend.
Oct 25, 2022 09:00 am ET
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022
via NewMediaWire - In the third calendar quarter (3Q) of 2022, despite significant cost inflation, supply chain disruption, litigation expenses and negative impact of a stronger U.S. Dollar on foreign currency sales, Utah Medical Products, Inc....
Aug 02, 2022 10:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / August 2, 2022 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-nine cents ($.29) per share of common stock payable on October 5, 2022 to shareholders of record at the close of business on September 16, 2022. This is a 1.8% increase over the dividend declared in the same quarter of the prior year.
Jul 26, 2022 09:00 am ET
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2022
via NewMediaWire --UTMD achieved second calendar quarter (2Q) and first half (1H) 2022 financial results better than those anticipated in its beginning of year projections. Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD =...
May 10, 2022 10:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / May 10, 2022 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-nine cents ($.29) per share of common stock payable on July 6, 2022 to shareholders of record at the close of business on June 17, 2022. This is a 1.8% increase over the dividend declared in the same quarter of the prior year.
Apr 26, 2022 09:00 am ET
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2022
via NewMediaWire – In the first calendar quarter (1Q) of 2022, Utah Medical Products, Inc. (Nasdaq: UTMD) attained financial results consistent with achieving its goals for calendar year 2022. Summary of results.The following is a summary...
Feb 08, 2022 10:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / February 8, 2022 / Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-nine cents ($.29) per share of common stock payable on April 5, 2022 to shareholders of record at the close of business on March 18, 2022. This is a 1.8% increase over the dividend declared in the same quarter of the prior year.
Feb 01, 2022 09:00 am ET
UTMD Reports Audited Year 2021 and Fourth Quarter Financial Performance
via NewMediaWire -- The fourth calendar quarter (4Q) of 2021 financial results demonstrate Utah Medical Products, Inc.’s (Nasdaq: UTMD’s) continuing performance improvement despite many challenges related to the corona virus pandemic including...
Nov 02, 2021 10:00 am ET
Utah Medical Products, Inc. Announces Special Dividend
SALT LAKE CITY, UT / ACCESSWIRE / November 2, 2021 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a special cash dividend of two dollars ($2.00) per share of common stock payable on December 29, 2021 to stockholders of record at the close of business on December 15, 2021. This dividend replaces the normal quarterly dividend, and will be paid in December rather than in early 2022.
Oct 26, 2021 09:00 am ET
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2021
via NewMediaWire -- The third calendar quarter (3Q) of 2021 financial results continued to demonstrate Utah Medical Products, Inc.’s (Nasdaq: UTMD’s) recovery after a time when there were restrictions on so-called nonessential medical procedures...
Aug 03, 2021 10:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / August 3, 2021 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight and one-half cents ($.285) per share of common stock payable on October 5, 2021 to shareholders of record at the close of business on September 16, 2021. This is about a 2% increase over the dividend declared in the same quarter of the prior year.
Jul 22, 2021 09:00 am ET
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2021
via NewMediaWire -- The second calendar quarter (2Q) of 2021 financial results were dramatically different from 2Q 2020 because 2Q 2020 results were the low point of Utah Medical Products, Inc.’s (Nasdaq: UTMD) performance during the COVID-19...
May 11, 2021 10:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / May 11, 2021 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight and one-half cents ($.285) per share of common stock payable on July 6, 2021 to shareholders of record at the close of business on June 15, 2021. This is about a 2% increase over the dividend declared in the same quarter of the prior year.
Apr 22, 2021 09:00 am ET
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2021
via NewMediaWire -- Because of the aberration in results which began in March 2020 due to the impact of restrictions on “nonessential” medical procedures, Utah Medical Products, Inc. (Nasdaq: UTMD) will report 2021 quarterly income statement...
Mar 01, 2021 10:00 am ET
Utah Medical Products, Inc. Terminates its Shareholder Rights Agreement
via NewMediaWire -- Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors, acting by unanimous written consent, terminated the Company’s Shareholder Rights Agreement, sometimes referred to as a “poison pill.” The Rights...
Feb 09, 2021 11:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / February 9, 2021 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight and one-half cents ($.285) per share of common stock payable on April 2, 2021 to shareholders of record at the close of business on March 17, 2021. This is about a 2% increase over the dividend declared in the same quarter of the prior year.
Jan 28, 2021 09:00 am ET
UTMD Reports Audited Year 2020 and Fourth Quarter Financial Performance
via NewMediaWire -- Utah Medical Products, Inc. (Nasdaq: UTMD) reports financial results for the fourth calendar quarter (4Q) which confirms a trend of recovery from the “COVID-19 depression” in 2Q 2020 caused by government policies restricting...
Nov 03, 2020 10:00 am ET
Utah Medical Products, Inc. Increases Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / November 3, 2020 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight and one-half cents ($.285) per share of common stock payable on January 5, 2021 to shareholders of record at the close of business on December 15, 2020. This is about a 2% increase over the prior quarterly cash dividend.
Oct 27, 2020 09:00 am ET
UTMD Reports Financial Performance for Third Quarter and Nine Months of Year 2020
via NewMediaWire --For the third calendar quarter (3Q) and first nine months (9M) of 2020, Utah Medical Products, Inc. (Nasdaq: UTMD) reports financial results described by CEO Kevin Cornwell as follows, “As stockholders know, the desire to...
Aug 11, 2020 10:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / August 11, 2020 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight cents ($.28) per share of common stock payable on October 5, 2020 to shareholders of record at the close of business on September 15, 2020. This is about a 2% increase over the dividend declared in the same quarter of the prior year.
Jul 28, 2020 09:00 am ET
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2020
via NEWMEDIAWIRE -- As many of the gynecology devices provided by Utah Medical Products, Inc. (Nasdaq: UTMD) are used in “nonessential” or “elective” procedures, as medical procedures have been reclassified during the COVID-19 pandemic, the...
May 07, 2020 10:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / May 7, 2020 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight cents ($.28) per share of common stock payable on July 3, 2020 to shareholders of record at the close of business on June 17, 2020. This is about a 2% increase over the dividend declared in the same quarter of the prior year.
Apr 23, 2020 09:00 am ET
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2020
via NEWMEDIAWIRE -- In the first calendar quarter (1Q) of 2020, Utah Medical Products, Inc. (Nasdaq: UTMD) attained results consistent with 1Q 2019, despite realizing a negative impact from the public response to the corona virus (COVID-19)....
Mar 23, 2020 02:00 pm ET
UTMD Postpones its 2020 Annual Stockholders’ Meeting for Three Months
via NEWMEDIAWIRE -- As stockholders of Utah Medical Products, Inc. (Nasdaq: UTMD) appreciate, as a result of the recent rapid spread of the COVID-19 (corona virus), the warnings/ advice/ mandates of government authorities and infection disease...
Feb 13, 2020 11:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / February 13, 2020 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight cents ($.28) per share of common stock payable on April 2, 2020 to shareholders of record at the close of business on March 13, 2020. This is a 2% increase over the dividend declared in the same quarter of the prior year.
Jan 30, 2020 10:03 am ET
UTMD Reports Audited Year 2019 and Fourth Quarter Financial Performance
In the final calendar quarter (4Q) of 2019, Utah Medical Products, Inc. (Nasdaq: UTMD) began to realize accretive profits net of the quarterly amortization of the purchase price paid to CooperSurgical Inc. (CSI) for the acquisition of exclusive...
Nov 05, 2019 10:00 am ET
Utah Medical Products, Inc. Increases Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / November 5, 2019 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight cents ($.28) per share of common stock payable on January 3, 2020 to shareholders of record at the close of business on December 13, 2019. This is a 2% increase over the prior quarterly cash dividend.
Oct 24, 2019 09:00 am ET
UTMD Reports Financial Performance for Third Quarter and Nine Months of Year 2019
via NEWMEDIAWIRE – In the third calendar quarter (3Q) and first nine months (9M) of 2019, Utah Medical Products, Inc. (Nasdaq: UTMD) attained results which reflect that the Company is likely to exceed its overall revenue growth goal, but fall...
Aug 08, 2019 10:00 am ET
Jul 30, 2019 09:00 am ET
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2019
In the second calendar quarter (2Q) and first half (1H) of 2019, Utah Medical Products, Inc. (Nasdaq: UTMD) attained results which reflect that the Company remains on target to achieve its financial goals for year 2019 despite the apparent negative...
May 07, 2019 10:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / May 7, 2019 / Utah Medical Products, Inc. (NASDAQ: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-seven and one-half cents ($.275) per share of common stock payable on July 3, 2019 to shareholders of record at the close of business on June 14, 2019. This is a 2% increase over the dividend declared in the same quarter of the prior year.
Apr 25, 2019 09:00 am ET
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2019
via NEWMEDIAWIRE -- In the first calendar quarter (1Q) of 2019, Utah Medical Products, Inc. (Nasdaq: UTMD) attained results consistent with achieving its financial goals for year 2019 despite a negative comparison with 1Q 2018 results. Summary of...
Feb 19, 2019 08:20 am ET
New Research Coverage Highlights Global Payments, Tableau Software, Summit Therapeutics, Utah Medical Products, Apollo Commercial Real Estate Finance, and Urstadt Biddle Properties — Consolidated Reve
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Global Payments Inc. (NYSE:GPN), Tableau Software, Inc. (NYSE:DATA),...
Feb 12, 2019 10:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / February 12, 2019 / Utah Medical Products, Inc. (NASDAQ: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-seven and one-half cents ($.275) per share of common stock payable on April 2, 2019 to shareholders of record at the close of business on March 15, 2019. This is a 2% increase over the dividend declared in the same quarter of the prior year.
Jan 31, 2019 09:00 am ET
UTMD Reports Audited Year 2018 and Fourth Quarter Financial Performance
via NEWMEDIAWIRE -- Excluding a large favorable adjustment correcting the U.S. repatriation tax (REPAT) on foreign subsidiary cash and cumulative earnings (E&P), Utah Medical Products, Inc. (Nasdaq: UTMD) concluded a solid year in 2018 in which it...
Dec 10, 2018 07:25 am ET
Analysis: Positioning to Benefit within Allegion, Las Vegas Sands, Select Income REIT, Utah Medical Products, Brunswick, and Lennar — Research Highlights Growth, Revenue, and Consolidated Results
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Allegion PLC (NYSE:ALLE), Las Vegas Sands Corp. (NYSE:LVS), Select Income...
Nov 01, 2018 07:30 am ET
Factors of Influence in 2018, Key Indicators and Opportunity within BP p.l.c, Nokia, Xcel Energy, Employers, Utah Medical Products, and Tractor Supply — New Research Emphasizes Economic Growth
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of BP p.l.c. (NYSE:BP), Nokia Corporation (NYSE:NOK), Xcel Energy Inc....
Oct 30, 2018 10:00 am ET
Utah Medical Products, Inc. Increases Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / October 30, 2018 / Utah Medical Products, Inc. (NASDAQ: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-seven and one-half cents ($.275) per share of common stock payable on January 3, 2019 to shareholders of record at the close of business on December 14, 2018. This is a 2% increase over the prior quarterly cash dividend.
Oct 23, 2018 09:00 am ET
Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2018
via NEWMEDIAWIRE -- In the third calendar quarter (3Q) and first nine months (9M) of 2018, Utah Medical Products, Inc. (Nasdaq: UTMD) achieved results which conform with its previously announced goals for 2018. Currencies in this report are...
Jul 31, 2018 10:35 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / July 31, 2018 / Utah Medical Products, Inc. (NASDAQ: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-seven cents ($.27) per share of common stock payable on October 2, 2018 to shareholders of record at the close of business on September 14, 2018. This is a 2% increase over the dividend declared in the same quarter of the prior year.
Jul 24, 2018 09:00 am ET
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2018
In the second calendar quarter (2Q) and first half (1H) of 2018, Utah Medical Products, Inc. (Nasdaq:UTMD) achieved results which reflect that the Company remains on target to achieve beginning of year goals for 2018. Currencies in this report are...
May 25, 2018 07:55 am ET
New Research Coverage Highlights Franklin Electric Co., ForeScout Technologies, State Bank Financial, Meta Financial Group, Utah Medical Products, and Live Oak Bancshares — Consolidated Revenues, Comp
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Franklin Electric Co., Inc. (NASDAQ:FELE), ForeScout Technologies, Inc....
May 08, 2018 10:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-seven cents ($.27) per share of common stock payable on July 6, 2018 to shareholders of record at the close of business on...
Apr 26, 2018 09:00 am ET
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2018
SALT LAKE CITY, April 26, 2018 (GLOBE NEWSWIRE) -- In the first calendar quarter (1Q) of 2018, Utah Medical Products, Inc. (Nasdaq:UTMD) attained results consistent with achieving its financial goals for year 2018.
Apr 03, 2018 08:00 am ET
Investor Expectations to Drive Momentum within Atrion, Curis, Independence Contract Drilling, Utah Medical Products, FutureFuel, and Opiant Pharmaceuticals — Discovering Underlying Factors of Influenc
NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Atrion Corporation (NASDAQ:ATRI), Curis, Inc. (NASDAQ:CRIS),...
Feb 13, 2018 10:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / February 13, 2018 / Utah Medical Products, Inc. (NASDAQ: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-seven cents ($.27) per share of common stock payable on April 3, 2018 to shareholders of record at the close of business on March 16, 2018. This is a 2% increase over the dividend declared in the same quarter of the prior year.
Feb 01, 2018 07:40 am ET
Report: Exploring Fundamental Drivers Behind Bryn Mawr Bank, Utah Medical Products, Opiant Pharmaceuticals, Whiting Petroleum, International Business Machines, and QUALCOMM — New Horizons, Emerging Tr
NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Bryn Mawr Bank Corporation (NASDAQ:BMTC), Utah...
Jan 30, 2018 09:00 am ET
Utah Medical Products, Inc. Reports Audited Financial Performance for Fourth Quarter and Year 2017
SALT LAKE CITY, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Utah Medical Products, Inc. (Nasdaq:UTMD) concluded an outstanding year in 2017 in which it harvested distribution changes that had been in the making for several years. Although UTMD substantially...
Oct 31, 2017 10:00 am ET
Utah Medical Products, Inc. Increases Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / October 31, 2017 / Utah Medical Products, Inc. (NASDAQ: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-seven cents ($.27) per share of common stock payable on January 3, 2018 to shareholders of record at the close of business on December 15, 2017. This is a 2% increase over the prior quarterly cash dividend.
Oct 24, 2017 09:00 am ET
Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2017
In the third calendar quarter (3Q) and first nine months (9M) of 2017, Utah Medical Products, Inc. (NASDAQ: UTMD) achieved results which confirm that the Company is very likely to significantly exceed its previously announced goals for 2017.
Jul 25, 2017 09:00 am ET
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2017
In the second calendar quarter (2Q) and first half (1H) of 2017, Utah Medical Products, Inc. (NASDAQ: UTMD) achieved results which suggest the Company may significantly exceed previously announced goals for 2017.
Apr 25, 2017 09:00 am ET
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2017
In the first calendar quarter (1Q) of 2017, Utah Medical Products, Inc. (NASDAQ: UTMD) achieved results representing a strong start to achieving its financial goals for year 2017.
Feb 07, 2017 10:00 am ET
Utah Medical Products, Inc. Announces Quarterly Dividend
Utah Medical Products, Inc. (NASDAQ: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-six and one-half cents ($.265) per share of common stock payable on April 4, 2017 to shareholders of record at the close of business on March 17, 2017. This is a 2% increase over the dividend declared in the same quarter of the prior year.
Jan 31, 2017 09:00 am ET
UTMD Reports Audited Financial Performance for Fourth Quarter and Year 2016
Utah Medical Products, Inc. (NASDAQ: UTMD) concluded a year in 2016 in which Operating Income (OI) and Earnings Per Share (EPS) per U.S. Generally Accepted Accounting Principles (US GAAP) were up 3% despite weak demand from its largest distributor and, in the second half (2H) of the year, despite the change in the foreign currency exchange (FX) rate of the Great Britain Pound (GBP or £ ) relative to the U.S. Dollar (USD or $).
Nov 01, 2016 10:00 am ET
Utah Medical Products, Inc. Increases Quarterly Dividend
Utah Medical Products, Inc. (NASDAQ: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-six and one half cents ($.265) per share of common stock payable on December 30, 2016 to shareholders of record at the close of business on December 16, 2016. This is a 2% increase over the prior quarterly cash dividend.
Jul 26, 2016 09:00 am ET
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2016
In the second calendar quarter (2Q) and first half (1H) of 2016, Utah Medical Products, Inc. (NASDAQ: UTMD) continued to achieve results which are on track to meet its previously announced goals for 2016.
Apr 26, 2016 09:00 am ET
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2016
In the first calendar quarter (1Q) of 2016, Utah Medical Products, Inc. (NASDAQ: UTMD) achieved results representing a solid start to meeting its previously announced goals for 2016.
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.